Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Oral prednisolone helps hair regrowth in alopecia areata.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Finasteride safety data in trials may be underreported or misrepresented.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Biologics for severe asthma have known side effects, but some new risks need more study.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

CTE can distort results in hair growth trials, so exclude it carefully.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

These medications for BPH have known risks and may have new side effects.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

These medications for BPH have known risks and may have new side effects.

Finasteride toxicity information is limited, poor quality, and biased.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.